Publisher Correction: Antiviral and clinical activity of bamlanivimab in a randomized trial of non-hospitalized adults with COVID-19

Kara W. Chew (), Carlee Moser, Eric S. Daar, David A. Wohl, Jonathan Z. Li, Robert W. Coombs, Justin Ritz, Mark Giganti, Arzhang Cyrus Javan, Yijia Li, Manish C. Choudhary, Rinki Deo, Carlos Malvestutto, Paul Klekotka, Karen Price, Ajay Nirula, William Fischer, Veenu Bala, Ruy M. Ribeiro, Alan S. Perelson, Courtney V. Fletcher, Joseph J. Eron, Judith S. Currier, Michael D. Hughes and Davey M. Smith
Additional contact information
Kara W. Chew: David Geffen School of Medicine at University of California, Los Angeles
Carlee Moser: Harvard T.H. Chan School of Public Health
Eric S. Daar: Lundquist Institute at Harbor-UCLA Medical Center
David A. Wohl: University of North Carolina at Chapel Hill School of Medicine
Jonathan Z. Li: Brigham and Women’s Hospital, Harvard Medical School
Robert W. Coombs: University of Washington
Justin Ritz: Harvard T.H. Chan School of Public Health
Mark Giganti: Harvard T.H. Chan School of Public Health
Arzhang Cyrus Javan: National Institutes of Health
Yijia Li: Brigham and Women’s Hospital, Harvard Medical School
Manish C. Choudhary: Brigham and Women’s Hospital, Harvard Medical School
Rinki Deo: Brigham and Women’s Hospital, Harvard Medical School
Carlos Malvestutto: Ohio State University Wexner Medical Center
Paul Klekotka: Eli Lilly and Company
Karen Price: Eli Lilly and Company
Ajay Nirula: Eli Lilly and Company
William Fischer: University of North Carolina at Chapel Hill School of Medicine
Veenu Bala: University of Nebraska Medical Center
Ruy M. Ribeiro: Los Alamos National Laboratory
Alan S. Perelson: Los Alamos National Laboratory
Courtney V. Fletcher: University of Nebraska Medical Center
Joseph J. Eron: University of North Carolina at Chapel Hill School of Medicine
Judith S. Currier: David Geffen School of Medicine at University of California, Los Angeles
Michael D. Hughes: Harvard T.H. Chan School of Public Health
Davey M. Smith: University of California, San Diego

Nature Communications, 2023, vol. 14, issue 1, 1-1

Date: 2023
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-023-35835-3 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:14:y:2023:i:1:d:10.1038_s41467-023-35835-3

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-023-35835-3

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().